A 7.0-7.7% value for glycated haemoglobin is better than a <7% value as an appropriate target for patient-centered drug treatment of type 2 diabetes mellitus
Ann Transl Med
.
2019 Jul;7(Suppl 3):S122.
doi: 10.21037/atm.2019.05.43.
Authors
José Pedro L Nunes
1
,
Joseph P DeMarco
2
Affiliations
1
Department of Medicine, Faculdade de Medicina da Universidade do Porto, Portugal.
2
Department of Philosophy, Cleveland State University, Cleveland, OH, USA.
PMID:
31576329
PMCID:
PMC6685886
DOI:
10.21037/atm.2019.05.43
No abstract available
Publication types
Editorial